Published • loading... • Updated
Recall Alert: Xanax Recalled Nationwide
- On April 15, Viatris, Inc. initiated a nationwide Class II recall for lot 8177156 of 3mg Xanax XR tablets after the medication failed dissolution specifications.
- The FDA classified the action as a Class II recall, meaning tablets may not dissolve at the intended rate and could cause temporary, reversible health effects.
- Separately, a 'looksmaxxing' influencer was hospitalized after a suspected overdose during a livestream, and a fire at Boston Medical Center forced an early Wednesday evacuation.
- Patients prescribed the affected medication should stop taking it and safely dispose of it, while pharmacies return stock to Viatris.
- Approximately 3.6 million Americans take Xanax, though the recall affects only one lot distributed through May 2025, leaving other batches and generics unaffected.
Insights by Ground AI
25 Articles
25 Articles
Batch of Anti-Anxiety Drug Xanax Recalled Over Safety Concerns
A single lot of a widely used anti-anxiety drug called Xanax has been recalled, the U.S. Food and Drug Administration (FDA) announced. The post Batch of Widely Used Anti-Anxiety Drug Xanax Recalled Over Safety Concerns appeared first on Breitbart.
·United States
Read Full ArticleFDA Issues Notice of Nationwide Recall of Common Anxiety Medication
The maker of Xanax is recalling a batch of the widely prescribed anxiety medication across the United States, according to a notice published by the Food and Drug Administration (FDA). U.S.-based pharmaceutical company Viatris Inc. is recalling Xanax, or alprazolam, because it failed to meet dissolution specifications, says the FDA report uploaded to its website this week. That means that a drug may not be able to deliver the correct dosage over…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources25
Leaning Left2Leaning Right6Center11Last UpdatedBias Distribution58% Center
Bias Distribution
- 58% of the sources are Center
58% Center
C 58%
R 32%
Factuality
To view factuality data please Upgrade to Premium















